Lucid Diagnostics Ownership | Who Owns Lucid Diagnostics?

Overview Forecast RevenueFinancials Chart Transcripts

Lucid Diagnostics Ownership Summary

Lucid Diagnostics is owned by 13.69% institutional investors, 34.22% insiders, and 52.09% retail investors. Luminus management is the largest institutional shareholder, holding 2.02% of LUCD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.03% of its assets in Lucid Diagnostics shares.

LUCD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lucid Diagnostics	13.69%	34.22%	52.09%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Medical Device Stocks	32.66%	10.50%	56.84%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Luminus management	1.02M	2.02%	$832.39K
Vanguard group	560.91K	1.11%	$459.39K
Sargent investment group	541.50K	1.07%	$442.41K
Geode capital management	279.50K	0.55%	$228.85K
Lido advisors	140.02K	0.28%	$114.63K
Nantahala capital management	94.54K	0.19%	$77.40K
Goldman sachs group	63.58K	0.13%	$52.05K
Hrt financial lp	59.64K	0.12%	$48.00K
Lpl financial	53.39K	0.11%	$43.71K
Blackrock	27.31K	0.06%	$22.39K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Luminus management	1.02M	0.96%	$832.39K
Sargent investment group	541.50K	0.07%	$442.41K
Byrne asset management	11.00K	0.01%	$9.56K
Nantahala capital management	94.54K	0.00%	$77.40K
Gotham asset management	10.44K	0.00%	$104.53K
Americana partners	26.43K	0.00%	$21.64K
Virtu financial	14.16K	0.00%	$12.00K
Lido advisors	140.02K	0.00%	$114.63K
Hrt financial lp	59.64K	0.00%	$48.00K
Tower research capital llc (trc)	7.17K	0.00%	$5.87K

Top Buyers

Holder	Shares	% Assets	Change
Sargent investment group	541.50K	0.07%	541.50K
Geode capital management	279.50K	-	65.96K
Goldman sachs group	63.58K	-	63.58K
Hrt financial lp	59.64K	0.00%	59.64K
Lido advisors	140.02K	0.00%	40.00K

Top Sellers

Holder	Shares	% Assets	Change
Luminus management	1.02M	0.96%	-136.19K
Levin capital strategies	-	-	-66.53K
Verition fund management	-	-	-39.71K
Nantahala capital management	94.54K	0.00%	-31.82K
Geneos wealth management	-	-	-29.55K

New Positions

Holder	Shares	% Assets	Change	Value
Sargent investment group	541.50K	0.07%	541.50K	$442.41K
Goldman sachs group	63.58K	-	63.58K	$52.05K
Hrt financial lp	59.64K	0.00%	59.64K	$48.00K
Americana partners	26.43K	0.00%	26.43K	$21.64K
Creative planning	11.85K	-	11.85K	$9.70K

Sold Out

Holder	Change
Thompson investment management	-1.00
Newedge advisors	-2.00
Ubs group	-2.00
Newbridge financial services group	-50.00
Qube research	-103.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	47	46.88%	9,415,056	184.29%	13	31.66%	31	63.16%	8	-
Dec 31, 2024	31	14.81%	3,227,778	31.56%	6	27.01%	18	80.00%	8	14.29%
Sep 30, 2024	27	-15.63%	2,453,404	23.06%	4	24.83%	10	-33.33%	7	-22.22%
Jun 30, 2024	32	14.29%	1,993,585	-3.75%	4	18.00%	15	-25.00%	9	50.00%
Mar 31, 2024	28	16.67%	2,071,204	18.45%	4	28.43%	20	150.00%	6	-25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.14M	2.03%	1.53M
Vanguard Institutional Extnd Mkt Idx Tr	276.27K	0.26%	-
Fidelity Extended Market Index	127.48K	0.12%	-10.17K
Fidelity Total Market Index	56.41K	0.05%	-
Vanguard Balanced Index Inv	41.88K	0.04%	41.88K
NT Ext Equity Mkt Idx Fd - L	26.20K	0.04%	14.93K
Fidelity Nasdaq Composite Index	38.29K	0.04%	-
Fidelity Series Total Market Index	31.35K	0.03%	6.20K
Spartan Extended Market Index Pool E	27.08K	0.03%	7.87K
Spartan Extended Market Index Pool F	27.08K	0.03%	7.87K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 22, 2025	Matheis Dennis	-	Buy	$43.79K
May 20, 2025	Matheis Dennis	-	Buy	$242.29K
May 21, 2025	Matheis Dennis	-	Buy	$171.52K
May 21, 2025	Matheis Dennis	-	Buy	$171.52K
May 22, 2025	Matheis Dennis	-	Buy	$43.79K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	6	-
2025 Q1	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q3	-	10

LUCD Ownership FAQ

Who Owns Lucid Diagnostics?

Lucid Diagnostics shareholders are primarily institutional investors at 13.69%, followed by 34.22% insiders and 52.09% retail investors. The average institutional ownership in Lucid Diagnostics's industry, Medical Device Stocks, is 32.66%, which Lucid Diagnostics falls below.

Who owns the most shares of Lucid Diagnostics?

Lucid Diagnostics’s largest shareholders are Luminus management (1.02M shares, 2.02%), Vanguard group (560.92K shares, 1.11%), and Sargent investment group (541.5K shares, 1.07%). Together, they hold 4.21% of Lucid Diagnostics’s total shares outstanding.

Does Blackrock own Lucid Diagnostics?

Yes, BlackRock owns 0.06% of Lucid Diagnostics, totaling 27.31K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 22.39K$. In the last quarter, BlackRock decreased its holdings by -24.336K shares, a -47.12% change.

Who is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested?

Luminus management is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 1.02M Lucid Diagnostics shares, valued at 832.39K$.

Who is the top mutual fund holder of Lucid Diagnostics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lucid Diagnostics shares, with 2.03% of its total shares outstanding invested in 2.14M Lucid Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools